Sanofi (SNY) Dividend Coverage Ratio (2009 - 2026)
Sanofi's (SNY) quarterly Dividend Coverage Ratio came in at 0.07 in Q2 2026, down 92.21% year-over-year from 0.84 in Q2 2025, and up 101.28% quarter-over-quarter from 5.11 in Q1 2026.
Analysis
Sanofi (SNY) Dividend Coverage Ratio (2009 - 2026) Analysis & Trends
Sanofi has disclosed Dividend Coverage Ratio across 18 years of filings, most recently posting 0.07 for Q2 2026.
- In Q2 2026, Dividend Coverage Ratio fell 92.21% year-over-year to 0.07; the TTM figure through Jun 2026 stood at 0.42 (up 79.88% YoY), while the FY2025 annual figure was 3.86, up 226.59% from the prior year.
- Dividend Coverage Ratio came in at 0.07 for Q2 2026 at Sanofi, up from 5.11 in the prior quarter.
- In the past five years, Dividend Coverage Ratio ranged from a high of 22.83 in Q1 2025 to a low of 5.11 in Q1 2026.
- Average Dividend Coverage Ratio over 5 years is 1.52, with a median of 0.11 recorded in 2024.
- Year-over-year, Dividend Coverage Ratio plunged 185.13% in 2024 and jumped 1406.37% in 2025.
- Over 5 years, Dividend Coverage Ratio stood at 1.26 in 2022, then jumped by 109.87% to 0.12 in 2023, then plunged by 185.13% to 0.11 in 2024, then soared by 1406.37% to 1.39 in 2025, then plunged by 95.28% to 0.07 in 2026.
- Per Business Quant data, the three most recent Dividend Coverage Ratio figures were 0.07 in Q2 2026, 5.11 in Q1 2026, and 1.39 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 648.10 Bn | 627.34 Bn | 17.26 Bn | 1.71 |
| 2 | AbbVie | 441.84 Bn | 435.27 Bn | 12.70 Bn | 1.18 |
| 3 | Merck | 364.97 Bn | 357.83 Bn | 12.21 Bn | -0.62 |
| 4 | Novartis Ag | 267.08 Bn | 259.39 Bn | 11.24 Bn | 1.14 |
| 5 | Pfizer | 158.83 Bn | 147.13 Bn | 10.94 Bn | -0.10 |
| 6 | Sanofi | 52.56 Bn | 45.18 Bn | 10.79 Bn | 0.07 |
| 7 | Revolution Medicines | 44.29 Bn | 44.29 Bn | - | - |
| 8 | Incyte | 25.35 Bn | 20.81 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn | - |
| 10 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.07 |
| Mar 31, 2026 | -5.11 |
| Dec 31, 2025 | 1.39 |
| Sep 30, 2025 | -0.90 |
| Jun 30, 2025 | 0.84 |
| Mar 31, 2025 | 22.83 |
| Dec 31, 2024 | -0.11 |
| Sep 30, 2024 | -0.60 |
| Dec 31, 2023 | 0.12 |
| Sep 30, 2023 | -0.57 |
| Dec 31, 2022 | -1.26 |
| Dec 31, 2021 | -1.27 |
| Dec 31, 2020 | -2.85 |
| Dec 31, 2019 | 0.00 |
| Dec 31, 2018 | -1.07 |
| Dec 31, 2017 | -0.03 |
| Dec 31, 2016 | -1.04 |
| Dec 31, 2015 | -1.07 |
| Dec 31, 2014 | -0.83 |
| Dec 31, 2013 | 0.73 |